Authors:
Coleiro, B
Marshall, SE
Denton, CP
Howell, K
Blann, A
Welsh, KI
Black, CM
Citation: B. Coleiro et al., Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine, RHEUMATOLOG, 40(9), 2001, pp. 1038-1043
Authors:
Braybrooke, JP
O'Byrne, KJ
Propper, DJ
Blann, A
Saunders, M
Dobbs, N
Han, C
Woodhull, J
Mitchell, K
Crew, J
Smith, K
Stephens, R
Ganesan, TS
Talbot, DC
Harris, AL
Citation: Jp. Braybrooke et al., A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis, CLIN CANC R, 6(12), 2000, pp. 4697-4704
Authors:
Herrick, AL
Hollis, S
Schofield, D
Rieley, F
Blann, A
Griffin, K
Moore, T
Braganza, JM
Jayson, MIV
Citation: Al. Herrick et al., A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis, CLIN EXP RH, 18(3), 2000, pp. 349-356
Authors:
Jilma, B
Blann, A
Pernerstorfer, T
Stohlawetz, P
Eichler, HG
Vondrovec, B
Amiral, J
Richter, V
Wagner, OF
Citation: B. Jilma et al., Regulation of adhesion molecules during human endotoxemia - No acute effects of aspirin, AM J R CRIT, 159(3), 1999, pp. 857-863
Authors:
Blann, A
Kumar, P
Krupinski, J
McCollum, C
Beevers, DG
Lip, GYH
Citation: A. Blann et al., Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke, BL COAG FIB, 10(5), 1999, pp. 277-284
Authors:
Blann, A
Hewitt, J
Siddiqui, F
Bareford, D
Citation: A. Blann et al., Racial background is a determinant of average warfarin dose required to maintain the INR between 2 center dot 0 and 3 center dot 0, BR J HAEM, 107(1), 1999, pp. 207-209
Authors:
Mutin, M
Canavy, I
Blann, A
Bory, M
Sampol, J
Dignat-George, F
Citation: M. Mutin et al., Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells, BLOOD, 93(9), 1999, pp. 2951-2958
Authors:
Dziadzio, M
Denton, CP
Smith, R
Howell, K
Blann, A
Bowers, E
Black, CM
Citation: M. Dziadzio et al., Losartan therapy for Raynaud's phenomenon and scleroderma - Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial, ARTH RHEUM, 42(12), 1999, pp. 2646-2655